Exact Mass: 1109.4235

Exact Mass Matches: 1109.4235

Found 19 metabolites which its exact mass value is equals to given mass value 1109.4235, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Coumermycin

Coumermycin A1

C55H59N5O20 (1109.3753)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic D004791 - Enzyme Inhibitors

   

Tetracosatetraenoyl CoA

(2R)-4-({[({[(2R,3R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-3,3-dimethyl-N-[2-({2-[(9Z,12Z,18Z)-tetracosa-9,12,15,18-tetraenoylsulphanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]butanimidic acid

C45H74N7O17P3S (1109.4075)


(9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA is an intermediate in the biosynthesis of unsaturated fatty acids. (9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA is the 1st to last step in the synthesis of (6Z,9Z,12Z,15Z,18Z)-Tetracosapentaenoyl-CoA and is converted from (7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA via the enzyme 3-oxoacyl-[acyl-carrier protein] reductase (EC 1.1.1.100) in multisteps.

   

all-cis-12,15,18,21-Tetracosatetraenoyl-CoA

(2R)-4-({[({[(2S,3S,4R,5S)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-3,3-dimethyl-N-[2-({2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoylsulfanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]butanimidic acid

C45H74N7O17P3S (1109.4075)


This compound belongs to the family of Acyl CoAs. These are organic compounds contaning a coenzyme A substructure linked to another moeity through an ester bond.

   

9Z,12Z,15Z,18Z-tetracosatetraenoyl-CoA

(2R)-4-({[({[(2R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-3,3-dimethyl-N-[2-({2-[(9Z,12Z,18Z)-tetracosa-9,12,15,18-tetraenoylsulphanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]butanimidic acid

C45H74N7O17P3S (1109.4075)


9Z,12Z,15Z,18Z-tetracosatetraenoyl-CoA is classified as a member of the Very long-chain fatty acyl CoAs. Very long-chain fatty acyl CoAs are acyl CoAs where the group acylated to the coenzyme A moiety is a very long aliphatic chain of 22 carbon atoms or more. 9Z,12Z,15Z,18Z-tetracosatetraenoyl-CoA is considered to be practically insoluble (in water) and acidic. 9Z,12Z,15Z,18Z-tetracosatetraenoyl-CoA is a fatty ester lipid molecule

   

Coumamycin

5-hydroxy-6-[(4-hydroxy-3-{5-[(4-hydroxy-7-{[3-hydroxy-5-methoxy-6,6-dimethyl-4-(5-methyl-1H-pyrrole-2-carbonyloxy)oxan-2-yl]oxy}-8-methyl-2-oxo-2H-chromen-3-yl)carbamoyl]-4-methyl-1H-pyrrole-3-amido}-8-methyl-2-oxo-2H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyloxan-4-yl 5-methyl-1H-pyrrole-2-carboxylate

C55H59N5O20 (1109.3753)


   

(9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoyl-CoA

4-({[({[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-3,3-dimethyl-N-(2-{[2-(tetracosa-9,12,15,18-tetraenoylsulphanyl)ethyl]-C-hydroxycarbonimidoyl}ethyl)butanimidic acid

C45H74N7O17P3S (1109.4075)


(9z,12z,15z,18z)-tetracosa-9,12,15,18-tetraenoyl-coa is an acyl-CoA or acyl-coenzyme A. More specifically, it is a (9Z_12Z_15Z_18Z)-tetracosa-9_12_15_18-tetraenoic acid thioester of coenzyme A. (9z,12z,15z,18z)-tetracosa-9,12,15,18-tetraenoyl-coa is an acyl-CoA with 24 fatty acid group as the acyl moiety attached to coenzyme A. Coenzyme A was discovered in 1946 by Fritz Lipmann (Journal of Biological Chemistry (1946) 162 (3): 743–744) and its structure was determined in the early 1950s at the Lister Institute in London. Coenzyme A is a complex, thiol-containing molecule that is naturally synthesized from pantothenate (vitamin B5), which is found in various foods such as meat, vegetables, cereal grains, legumes, eggs, and milk. More specifically, coenzyme A (CoASH or CoA) consists of a beta-mercaptoethylamine group linked to the vitamin pantothenic acid (B5) through an amide linkage and 3-phosphorylated ADP. Coenzyme A is synthesized in a five-step process that requires four molecules of ATP, pantothenate and cysteine. It is believed that there are more than 1100 types of acyl-CoA’s in the human body, which also corresponds to the number of acylcarnitines in the human body. Acyl-CoAs exists in all living species, ranging from bacteria to plants to humans. The general role of acyl-CoA’s is to assist in transferring fatty acids from the cytoplasm to mitochondria. This process facilitates the production of fatty acids in cells, which are essential in cell membrane structure. Acyl-CoAs are also susceptible to beta oxidation, forming, ultimately, acetyl-CoA. Acetyl-CoA can enter the citric acid cycle, eventually forming several equivalents of ATP. In this way, fats are converted to ATP -- or biochemical energy. Acyl-CoAs can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain acyl-CoAs; 2) medium-chain acyl-CoAs; 3) long-chain acyl-CoAs; and 4) very long-chain acyl-CoAs; 5) hydroxy acyl-CoAs; 6) branched chain acyl-CoAs; 7) unsaturated acyl-CoAs; 8) dicarboxylic acyl-CoAs and 9) miscellaneous acyl-CoAs. Short-chain acyl-CoAs have acyl-groups with two to four carbons (C2-C4), medium-chain acyl-CoAs have acyl-groups with five to eleven carbons (C5-C11), long-chain acyl-CoAs have acyl-groups with twelve to twenty carbons (C12-C20) while very long-chain acyl-CoAs have acyl groups with more than 20 carbons. (9z,12z,15z,18z)-tetracosa-9,12,15,18-tetraenoyl-coa is therefore classified as a very long chain acyl-CoA. The oxidative degradation of fatty acids is a two-step process, catalyzed by acyl-CoA synthetase/synthase. Fatty acids are first converted to their acyl phosphate, the precursor to acyl-CoA. The latter conversion is mediated by acyl-CoA synthase. Three types of acyl-CoA synthases are employed, depending on the chain length of the fatty acid. (9z,12z,15z,18z)-tetracosa-9,12,15,18-tetraenoyl-coa, being a very long chain acyl-CoA is a substrate for very long chain acyl-CoA synthase. The second step of fatty acid degradation is beta oxidation. Beta oxidation occurs in mitochondria and, in the case of very long chain acyl-CoAs, the peroxisome. After its formation in the cytosol, (9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoyl-CoA is transported into the mitochondria, the locus of beta oxidation. Transport of (9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoyl-CoA into the mitochondria requires carnitine palmitoyltransferase 1 (CPT1), which converts (9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoyl-CoA into (9Z_12Z_15Z_18Z)-tetracosa-9_12_15_18-tetraenoylcarnitine, which gets transported into the mitochondrial matrix. Once in the matrix, (9Z_12Z_15Z_18Z)-tetracosa-9_12_15_18-tetraenoylcarnitine is converted back to (9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoyl-CoA by CPT2, whereupon beta-oxidation can begin. Beta oxidation of (9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoyl-CoA occurs in four steps. First, since (9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoyl-CoA is a very long chain ac...

   
   

(Galβ1-4[Fucα1-3]GlcNAcβ)2-Sp

(Galβ1-4[Fucα1-3]GlcNAcβ)2-Sp

C42H71N5O29 (1109.4235)


   

Galβ1-3[Fucα1-4]GlcNAcβ1-3Galβ1-4[Fucα1-3]GlcNAcβ-Sp

Galβ1-3[Fucα1-4]GlcNAcβ1-3Galβ1-4[Fucα1-3]GlcNAcβ-Sp

C42H71N5O29 (1109.4235)


   

CoA(24:4(9Z,12Z,15Z,18Z))

9Z,12Z,15Z,18Z-tetracosatetraenoyl-CoA

C45H74N7O17P3S (1109.4075)


   

Coumamycin

5-hydroxy-6-[(4-hydroxy-3-{5-[(4-hydroxy-7-{[3-hydroxy-5-methoxy-6,6-dimethyl-4-(5-methyl-1H-pyrrole-2-carbonyloxy)oxan-2-yl]oxy}-8-methyl-2-oxo-2H-chromen-3-yl)carbamoyl]-4-methyl-1H-pyrrole-3-amido}-8-methyl-2-oxo-2H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyloxan-4-yl 5-methyl-1H-pyrrole-2-carboxylate

C55H59N5O20 (1109.3753)


   

(2E,15Z)-tetracosadienoyl-CoA(4-)

(2E,15Z)-tetracosadienoyl-CoA(4-)

C45H74N7O17P3S-4 (1109.4075)


   

(9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoyl-CoA

(9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoyl-CoA

C45H74N7O17P3S (1109.4075)


   

(12Z,15Z,18Z,21Z)-tetracosatetraenoyl-CoA

(12Z,15Z,18Z,21Z)-tetracosatetraenoyl-CoA

C45H74N7O17P3S (1109.4075)


An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (12Z,15Z,18Z,21Z)-tetracosatetraenoic acid.

   

(9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA; (Acyl-CoA); [M+H]+

(9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA; (Acyl-CoA); [M+H]+

C45H74N7O17P3S (1109.4075)


   

Coumermycin A1

Coumermycin A1

C55H59N5O20 (1109.3753)


A hydroxycoumarin antibiotic that is obtained from Streptomyces rishiriensis and exhibits potent antibacterial and anticancer activity. D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic D004791 - Enzyme Inhibitors

   

CoA 24:4

24:4(n-6);9Z,12Z,15Z,18Z-Tetracosatetraenoyl-CoA;all-cis-9,12,15,18-tetracosatetraenoyl-CoA;tetracosatetraenoyl-CoA

C45H74N7O17P3S (1109.4075)


An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (9Z,12Z,15Z,18Z)-tetracosatetraenoic acid. It is a member of the n-6 PUFA and is the product of linoleic acid metabolism.

   

(2E,15Z)-tetracosadienoyl-CoA(4-)

(2E,15Z)-tetracosadienoyl-CoA(4-)

C45H74N7O17P3S (1109.4075)


A 2,3-trans-enoyl CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of (2E,15Z)-tetracosadienoyl-CoA; major species at pH 7.3.

   

n2,n4-bis(4-hydroxy-7-{[(2r,3r,4s,5r)-3-hydroxy-5-methoxy-6,6-dimethyl-4-(5-methyl-1h-pyrrole-2-carbonyloxy)oxan-2-yl]oxy}-8-methyl-2-oxochromen-3-yl)-3-methyl-1h-pyrrole-2,4-dicarboximidic acid

n2,n4-bis(4-hydroxy-7-{[(2r,3r,4s,5r)-3-hydroxy-5-methoxy-6,6-dimethyl-4-(5-methyl-1h-pyrrole-2-carbonyloxy)oxan-2-yl]oxy}-8-methyl-2-oxochromen-3-yl)-3-methyl-1h-pyrrole-2,4-dicarboximidic acid

C55H59N5O20 (1109.3753)